据阿尔及利亚Algérie360网站12月3日报道，阿正持续推进医药自主战略，在胰岛素、抗 癌药物及激素类药物等关键领域取得重要成绩，并逐步向多个非洲国家出口国产药 品。阿的医药产业正迈向"主权化"和国际化的双重轨道。 （原标题：阿尔及利亚构建医药自主体系） 阿目前已拥有超过230家制药企业和780条生产线。这是该国医药产业增长的关键 指标，也体现了阿方希望成为非洲与地中海地区重要制药中心的战略意图。 阿医药工业部监察总长介绍了国家医药产业的发展方向。阿正大规模扩大本地生产能 力、吸引全球药企技术，并将卫生主权建设作为产业政策核心之一。阿方正与多家国 际领先实验室建立战略性合作伙伴关系，目标是获取最新的国际医药创新技术。他宣 布，国家已批准 100 个新的医药生产项目，这些项目将显著加强本土生产能力，并提 高国产药品的质量水平。 ...

Core Viewpoint - Algeria's government is enhancing its pharmaceutical industry by establishing new production facilities in the southern provinces to achieve self-sufficiency and ensure national drug supply [1] Group 1: New Production Facilities - The state-owned pharmaceutical group Saidal will build new drug production plants in the southern provinces of Ouled Djellal, Ouargla, and Tamanrasset [1] - The new factories aim to decentralize production and better meet regional demands while strengthening industrial development in the south [1] Group 2: Economic and Employment Impact - The initiative is expected to create job opportunities and promote economic development in the inland and southern provinces [1] - Collaboration with the Algerian Investment Promotion Agency will support the development of pharmaceutical projects utilizing local land resources [1] Group 3: Local Production Goals - Plans include the local production of key pharmaceutical raw materials, covering diabetes medications, cancer drugs, heart disease treatments, and antibiotics [1] - Some strategic projects are anticipated to commence production by the end of 2026, with local production of dental anesthetics starting next year to address supply shortages [1] Group 4: Overall Objectives - The overarching goals are to enhance the autonomy of the pharmaceutical industry, reduce reliance on imports, ensure drug supply, and promote balanced economic development across regions [1]